We are live on ! Find out more
TI

Telemetry Investments Portfolio holdings

AUM $63.3M
1-Year Est. Return 0.06%
This Fund
S&P 500
This Quarter Est. Return
+6.18%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
AUM
$223M
AUM Growth
+$45.8M
Cap. Flow
+$17.2M
Cap. Flow %
7.73%
Top 10 Hldgs %
59.88%
Holding
149
New
49
Increased
28
Reduced
17
Closed
36

Top Sells

Rank Stock Value
1
IOC
Interoil Corporation
IOC
+$2.47M
2
AMZN icon
Amazon
AMZN
+$1.95M
3
AEPI
AEP Industries Inc
AEPI
+$1.75M
4
HUM icon
Humana
HUM
+$1.73M
5
MON
Monsanto Co
MON
+$1.44M

Sector Composition

Rank Sector Weight
1 Healthcare 8.15%
2 Consumer Staples 3.6%
3 Materials 2.85%
4 Technology 2.53%
5 Financials 2.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UUP icon
26
CALL
Invesco DB US Dollar Index Bullish Fund
UUP
$426M
$1.3M 0.58%
+50,000
New +$1.3M
MBLY
27
DELISTED
Mobileye N.V.
MBLY
$1.23M 0.55%
+20,000
New +$962K
ZLTQ
28
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$1.11M 0.5%
+20,000
New +$1M
WGL
29
DELISTED
Wgl Holdings
WGL
$1.1M 0.49%
+13,309
New +$1.08M
CHMT
30
DELISTED
Chemtura Corporation
CHMT
$1.07M 0.48%
32,000
+4,000
+14% +$133K
FPRX
31
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$983K 0.44%
+27,200
New +$1.2M
MPSX
32
DELISTED
Multi Packaging Solutions Intl.
MPSX
$834K 0.37%
+46,484
New +$794K
XOM icon
33
ExxonMobil
XOM
$642B
$820K 0.37%
+10,000
New +$835K
TVTX icon
34
Travere Therapeutics
TVTX
$5.27B
$812K 0.36%
44,000
+6,000
+16% +$117K
NMBL
35
DELISTED
Nimble Storage, Inc.
NMBL
$762K 0.34%
+61,000
New +$597K
CVS icon
36
CALL
CVS Health
CVS
$137B
$754K 0.34%
+9,600
New +$766K
CVS icon
37
PUT
CVS Health
CVS
$137B
$754K 0.34%
+9,600
New +$766K
XLRN
38
DELISTED
Acceleron Pharma
XLRN
$740K 0.33%
27,970
-8,560
-23% -$226K
JNS
39
DELISTED
Janus Capital Group Inc
JNS
$739K 0.33%
56,000
+6,000
+12% +$76.7K
ABUS icon
40
Arbutus Biopharma
ABUS
$871M
$731K 0.33%
225,000
+75,000
+50% +$208K
EVER
41
DELISTED
Everbank Financial Corp
EVER
$729K 0.33%
37,409
+4,297
+13% +$83.5K
WR
42
DELISTED
Westar Energy Inc
WR
$725K 0.33%
13,360
+1,000
+8% +$54.4K
FATE icon
43
Fate Therapeutics
FATE
$283M
$682K 0.31%
150,000
+26,500
+21% +$96.9K
CST
44
DELISTED
CST Brands, Inc.
CST
$673K 0.3%
14,000
+3,000
+27% +$145K
SCNB
45
DELISTED
Suffolk Bancorp
SCNB
$642K 0.29%
15,880
USO icon
46
PUT
United States Oil Fund
USO
$2.07B
$638K 0.29%
7,500
-5,000
-40% -$443K
GLBL
47
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
$638K 0.29%
+133,000
New +$601K
MGI
48
DELISTED
MoneyGram International, Inc. New
MGI
$577K 0.26%
+34,308
New +$462K
CRIS icon
49
Curis
CRIS
$9.14M
$564K 0.25%
101
+8
+9% +$44.5K
RIGL icon
50
Rigel Pharmaceuticals
RIGL
$692M
$563K 0.25%
17,000
+1,831
+12% +$46.7K

Similar funds

Telemetry Investments's Q1 2017 Portfolio in Review

As of Q1 2017, Telemetry Investments held 149 positions worth $223M, up 26% from $177M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Telemetry Investments deployed $17.2M of net new capital in Q1 2017, opening 49 new positions and adding to 28 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 14,000 shares worth $3.3M.

By sector, the portfolio is most concentrated in Healthcare at 8.2% of assets, up from 5.6% a quarter earlier, followed by Consumer Staples and Materials.

On the sell side, the largest reduction was Humana, an estimated $1.73M trimmed.

  • Telemetry Investments's largest Q1 2017 buy was State Street SPDR S&P 500 ETF Trust: 14,000 shares worth $3.3M.
  • Telemetry Investments added most to Kadmon Holdings, Inc. in Q1 2017, an estimated $4.96M increase.
  • Telemetry Investments's biggest Q1 2017 reduction was Humana, cutting an estimated $1.73M.
  • Telemetry Investments fully exited Interoil Corporation in Q1 2017, selling an estimated $2.47M.
  • Telemetry Investments's ten largest holdings make up 60% of its $223M portfolio in Q1 2017.
  • Telemetry Investments opened 49 new positions and closed 36 in Q1 2017.
  • Telemetry Investments's portfolio value rose 26% quarter-over-quarter to $223M.

Based on Telemetry Investments's 13F filing for Q1 2017, filed 15 May 2017.